DE1125587B - Roentgenkontrastmittel - Google Patents

Roentgenkontrastmittel

Info

Publication number
DE1125587B
DE1125587B DESCH21689A DESC021689A DE1125587B DE 1125587 B DE1125587 B DE 1125587B DE SCH21689 A DESCH21689 A DE SCH21689A DE SC021689 A DESC021689 A DE SC021689A DE 1125587 B DE1125587 B DE 1125587B
Authority
DE
Germany
Prior art keywords
acid
solution
diamino
contrast media
ray contrast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DESCH21689A
Other languages
German (de)
English (en)
Inventor
Dr Paul Diedrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DESCH21689A priority Critical patent/DE1125587B/de
Priority to NL224625A priority patent/NL104758C/xx
Priority to GB367858A priority patent/GB867880A/en
Priority to FR758437A priority patent/FR1282518A/fr
Priority to BE564991D priority patent/BE564991A/xx
Publication of DE1125587B publication Critical patent/DE1125587B/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452Solutions, e.g. for injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DESCH21689A 1957-03-06 1957-03-06 Roentgenkontrastmittel Pending DE1125587B (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DESCH21689A DE1125587B (de) 1957-03-06 1957-03-06 Roentgenkontrastmittel
NL224625A NL104758C (US07166745-20070123-C00061.png) 1957-03-06 1958-02-04
GB367858A GB867880A (en) 1957-03-06 1958-02-04 N-acyl derivatives of (3:5-diamino-2:4:6-triiodobenzoyl)-amino acids and x-ray contrast media containing the same
FR758437A FR1282518A (fr) 1957-03-06 1958-02-17 Dérivés nu-acylés d'acides (3.5-diamino-2. 4. 6-tri-iodo-benzoyl)-aminés
BE564991D BE564991A (US07166745-20070123-C00061.png) 1957-03-06 1958-02-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESCH21689A DE1125587B (de) 1957-03-06 1957-03-06 Roentgenkontrastmittel

Publications (1)

Publication Number Publication Date
DE1125587B true DE1125587B (de) 1962-03-15

Family

ID=7429122

Family Applications (1)

Application Number Title Priority Date Filing Date
DESCH21689A Pending DE1125587B (de) 1957-03-06 1957-03-06 Roentgenkontrastmittel

Country Status (5)

Country Link
BE (1) BE564991A (US07166745-20070123-C00061.png)
DE (1) DE1125587B (US07166745-20070123-C00061.png)
FR (1) FR1282518A (US07166745-20070123-C00061.png)
GB (1) GB867880A (US07166745-20070123-C00061.png)
NL (1) NL104758C (US07166745-20070123-C00061.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795555A (fr) * 1972-02-16 1973-08-16 Schering Ag Amides de triiodo-isophtaloyl-monoamino-acide, leur procede de preparation et leur utilisation
DE19875047I2 (de) * 1984-02-29 2001-08-09 Koehler Chemie Dr Franz N,N-(3,5-Diacetamido-2,4,6-triiodbenzoyl)-aminoacyl-N-methylglucamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Röntgenkontrastmittel.
US5563127A (en) * 1993-03-24 1996-10-08 The Dupont Merck Pharmaceutical Company Boronic acid and ester inhibitors of thrombin
ES2443242T3 (es) * 2005-12-23 2014-02-18 Zealand Pharma A/S Compuestos modificados miméticos de lisina
CN117986193A (zh) * 2022-11-01 2024-05-07 科睿驰(深圳)医疗科技发展有限公司 显影化合物及其制备方法、显影栓塞材料及其制备方法

Also Published As

Publication number Publication date
BE564991A (US07166745-20070123-C00061.png) 1960-07-15
FR1282518A (fr) 1962-01-27
NL104758C (US07166745-20070123-C00061.png) 1963-05-15
GB867880A (en) 1961-05-10

Similar Documents

Publication Publication Date Title
DE2559866C2 (de) 2,4,6-Trijodbenzoesäure-Derivate und ihre Verwendung als Kontrastmittel für Röntgenaufnahmen
DE2624153C2 (de) N,N'-acylamido-trijod-benzoylierte Alkylendiamine, Verfahren zu ihrer Herstellung und ihre Verwendung als Kontrastmittel für Röntgenaufnahmen
DE2732825A1 (de) 2,4,6-trijodbenzoesaeurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende roentgenkontrastmittel
DE1287081B (de) Verfahren zur Herstellung von N, N'-Bis-(3-amino-5-carboxy-2, 4, 6-trijodphenyl)-alkandicarbonsaeureamiden oder der entsprechenden Kohlensaeurediamide
DE1125587B (de) Roentgenkontrastmittel
AT209895B (de) Verfahren zur Herstellung von 3-Amino-2,4,6-trijodbenzoylverbindungen
DE2008332C3 (de) 2-Methyl-S-methoxy-3-indolylacetohydroxamsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2658300A1 (de) 3,5-bis-(acylamino)-benzamide
DE1493513C3 (de) Sulfamylanthranilsäuren, deren therapeutisch verwendbare Salze, Verfahren zu ihrer Herstellung und diese enthaltenden pharmazeutischen Präparate
AT206578B (US07166745-20070123-C00061.png)
DE1812937C3 (de) 4-(Ammoäthansulfonylamino)-antipyrine und Aminoäthansulfonyl-p-phenetidine sowie Verfahren zu ihrer Herstellung
DE2643841A1 (de) 3,5-disubst.-2,4,6-trijodanilide von einbasischen polyhydroxysaeuren
DE2301358B2 (de) Verfahren zur Herstellung von Hydroxy-L-prolin oder N-Acetyl-hydroxy-L-prolin aus hydrolysierter Gelatine
AT368153B (de) Verfahren zur herstellung des neuen n-(1'-allylpyrrolidin-2'-yl-methyl)-2-methoxy-4,5- azimidobenzamides und seiner saeureadditionssalze
AT207997B (de) Röntgenkontrastmittel
DE1166782B (de) Verfahren zur Herstellung von substituierten aromatischen Dicarbonsaeureimiden und deren Salzen
DE1443297C3 (de) 20.07.61 USA 125373 5-Amino-2,4,6-trijodisophthalamidsäurederivate Verfahren zu ihrer Herstellung und diese enthaltende Röntgenkontrastmittel Mallinckrodt Chemical Works, St. Louis, Mo. (V.St.A.)
DE2132614A1 (de) Jodierte N-Acyl-Derivate von aromatischen Amino-Carbonsaeuren
AT164031B (de) Verfahren zur Herstellung von 2,4,6-Triaminophenyl-mono-äthern
DE814445C (de) Verfahren zur Herstellung von Abkoemmlingen des Methionins
DE1117135B (de) Verfahren zur Herstellung von 3-Amino-2, 4, 6-trijodbenzoylverbindungen
AT213864B (de) Verfahren zur Herstellung von neuen analgetisch wirksamen α-Amino-β-oxybuttersäureamiden
AT236363B (de) Verfahren zur Herstellung von Tetracyano-benzochinon-(1,4)
DE2503315C3 (de) Verfahren zur Herstellung von Tyramin und dessen Säureadditionssalzen
AT334356B (de) Verfahren zum herstellen des neuen (l,d oder dl) -5-hydroxytryptophan- (l,d oder dl) -glutamats